Xconomy National

Archives

by in

Entry	Author	Date	Location
OncoSec Medical Advancing Inovio’s Technology Against Cancer	Bruce V. Bigelow	02/08/12	San Diego
Applied Proteomics, Co-Founded by Danny Hillis, Gets New CEO, $22.5M	Bruce V. Bigelow	02/07/12	San Diego
Dendreon Names John Johnson CEO After Volatile Year	Arlene Weintraub	02/01/12	Seattle
Cell Therapeutics Pulls FDA Application, Saying It Isn’t Ready For Panel	Luke Timmerman	01/30/12	Seattle
Infinity Drug Fails in Pancreatic Cancer Trial, Shares Fall	Luke Timmerman	01/27/12	Boston
OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation	Luke Timmerman	01/27/12	Seattle
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers	Erin Kutz	01/27/12	Boston
Verastem Bucks the Trend, Raises $55M in IPO	Luke Timmerman	01/26/12	Boston
San Diego Life Sciences Roundup: Illumina, Sequenom, Acutus, & More	Bruce V. Bigelow	01/26/12	San Diego
Millennium Wins FDA OK for New Velcade, Looks to Fend Off Onyx	Luke Timmerman	01/23/12	Boston
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting	Luke Timmerman	01/23/12	National
Infinity Offers Hint Of Effect With Pancreatic Cancer Drug	Luke Timmerman	01/20/12	Boston
Genzyme, Veracyte Strike Deal to Market Thyroid Cancer Diagnostic	Luke Timmerman	01/20/12	San Francisco
Millennium, Looking to Fend Off Onyx, Awaits FDA Word on New Velcade	Luke Timmerman	01/20/12	Boston
Onyx, Bayer’s Next Cancer Drug Shows Slim Survival Edge	Luke Timmerman	01/17/12	San Francisco
Seattle Genetics Sees Updated Side Effect Warning in Drug Label	Luke Timmerman	01/13/12	Seattle
San Diego Life Sciences News: AnaptysBio, Life, NeuroGenetic & More	Bruce V. Bigelow	01/12/12	San Diego
Forma Reels In J&J With $700M Deal; 2nd Cancer Drug Discovery Partner in a Week	Luke Timmerman	01/10/12	Boston
Langer, Farokhzad Start New Combo Drug Company, Blend Therapeutics	Luke Timmerman	01/06/12	Boston
San Diego Life Sciences Roundup: Isis, Elevation, Proacta, and More	Bruce V. Bigelow	01/06/12	San Diego
Dendreon Surprises With $82M in Fourth Quarter Sales, Stock Booms	Luke Timmerman	01/05/12	Seattle
Forma Cuts $65M Deal With Boehringer Ingelheim to Discover Cancer Drugs	Luke Timmerman	01/05/12	Boston
Diabetes Drugs Could Cure Cancer	N. Anthony Coles	01/03/12	San Francisco
Aveo (Barely) Passes Study With Kidney Cancer Drug, Stock Falls	Luke Timmerman	01/03/12	Boston
San Diego Life Sciences Roundup: Intellikine, Somaxon, and More	Bruce V. Bigelow	12/22/11	San Diego
Millennium: Takeda Acquires San Diego’s Intellikine for $190M Upfront	Luke Timmerman	12/20/11	Boston
Amgen, Watson Strike $400M Deal for Biosimilar Cancer Drugs	Luke Timmerman	12/19/11	National
Ariad Loads Up With $200M Stock Deal, After Big Medical Meeting	Luke Timmerman	12/15/11	Boston
Hutch Spinoff Presage Biosciences Shuffles Management	Luke Timmerman	12/15/11	Seattle
Onyx Drug Effective in New Myeloma Patients, Taking Aim at Millennium	Luke Timmerman	12/12/11	San Francisco
Page 1 of 41	next page »